SCHEMBL4545013

SCHEMBL4545013

COC(=O)CCCC(C)(C)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.50
CNR2 P34972 2/20 0.50
LMNA P02545 3/20 0.47
TSHR P16473 2/20 0.45
AKT1 P31749 1/20 0.45
KCNN4 O15554 1/20 0.44
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
CYP2C19 P33261 1/20 0.41
HIF1A Q16665 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA12 O43570 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10387238 0.95 CNR1 (0.55) CNR1CNR2LMNATSHRAKT1
SCHEMBL19454902 0.94 CNR1 (0.54) CNR1CNR2LMNATSHRAKT1
SCHEMBL4679670 0.90 CNR1 (0.52) CNR1CNR2LMNATSHRAKT1
SCHEMBL15160832 0.85 CYP2C19 (0.43) CNR1CNR2KCNN4ALDH1A1KDM4E
SCHEMBL12504415 0.85 CNR1 (0.40) CNR1CNR2KCNN4ALDH1A1KDM4E
SCHEMBL15316130 0.85 CNR2 (0.59) CNR1CNR2LMNATSHRALDH1A1
SCHEMBL10410114 0.85 CNR1 (0.55) CNR1CNR2LMNATSHRALDH1A1
SCHEMBL19118412 0.83 LMNA (0.47) LMNATSHRAKT1KCNN4ALDH1A1
SCHEMBL6885186 0.83 CNR1 (0.54) CNR1CNR2TSHRKMT2A
SCHEMBL10387817 0.83 AKR1C3 (0.47) CNR1CNR2LMNAAKT1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11793074-B2 Organic compound and photoelectric conversion element CANON KABUSHIKI KAISHA (JP) 2023-10-17 US disclosed
US-20230309372-A1 FULLERENE DERIVATIVE BLENDS, METHODS OF MAKING AND USES THEREOF NANO-C, INC. 2023-09-28 US disclosed
US-20230301185-A1 COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-09-21 US disclosed
US-11706971-B2 Fullerene derivative blends, methods of making and uses thereof NANO-C, INC. (US) 2023-07-18 US disclosed
US-20230145492-A1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, IMAGE PICKUP ELEMENT, AND IMAGE PICKUP APPARATUS CANON KK (JP) 2023-05-11 US disclosed
US-9972801-B2 Forming of optoelectronic devices, particularly of inverted-type OPV cells COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2018-05-15 US disclosed
US-9899617-B2 Production method of hole blocking layer, hole blocking layer, photoelectric conversion element, photoelectric conversion device, organic thin-film solar cell panel, and light-emitting device IDEAL STAR INC. (JP) 2018-02-20 US disclosed
US-20170338415-A1 ORGANIC SEMICONDUCTOR SOLUTION BLENDS FOR SWITCHING AMBIPOLAR TRANSPORT TO N-TYPE TRANSPORT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-23 US disclosed
US-20170294585-A1 FULLERENE MIXTURES FOR USE IN ORGANIC ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-10-12 US disclosed
US-20170104170-A1 FORMING OF OPTOELECTRONIC DEVICES, PARTICULARLY OF INVERTED-TYPE OPV CELLS COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2017-04-13 US disclosed
US-8729387-B2 Organic photoelectric conversion element, solar cell and optical sensor array KONICA MINOLTA HOLDINGS, INC. (JP) 2014-05-20 US disclosed
US-20130270545-A1 POLYMER COMPOUND HAVING CARBON CLUSTER STRUCTURE AND ORGANIC DEVICE USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-10-17 US disclosed
US-20120211730-A1 Hole Blocking Layer and Method for Producing Same, and Photoelectric Conversion Element Comprising the Hole Blocking Layer and Method for Manufacturing Same IDEAL STAR INC. (JP) 2012-08-23 US disclosed
US-20120111411-A1 FULLERENE DERIVATIVE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2012-05-10 US disclosed
US-20110130588-A1 COMPOSITION, AND ORGANIC PHOTOELECTRIC CONVERSION ELEMENT COMPRISING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-02 US disclosed
US-20110089380-A1 Fullerene Multi-Adduct Compositions SOLENNE BV 2011-04-21 US disclosed
US-20110089380-A1 Fullerene Multi-Adduct Compositions SOLENNE BV 2011-04-21 US disclosed
US-20110036406-A1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL AND OPTICAL SENSOR ARRAY KONICA MINOLTA HOLDINGS, INC. (JP) 2011-02-17 US disclosed
US-20100193033-A1 COMPOSITION AND ORGANIC PHOTOELECTRIC CONVERTER SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-08-05 US disclosed
WO-2009039490-A2 FULLERENE MULTI-ADDUCT COMPOSITIONS SOLENNE BV (NL) 2009-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130588-A1 COMPOSITION, AND ORGANIC PHOTOELECTRIC CONVERSION ELEMENT COMPRISING SAME PPA1, PHOSPHO1, TTR CNR1 4577/4885CNR2 4109/4885LMNA 2586/4885
US-20170294585-A1 FULLERENE MIXTURES FOR USE IN ORGANIC ELECTRONIC DEVICES OR10J3, PPOX, OCIAD2 CNR1 1839/4885CNR2 1571/4885LMNA 4770/4885
US-11793074-B2 Organic compound and photoelectric conversion element CRY1, CYP1A1, CCNE2 CNR1 3010/4885CNR2 3577/4885LMNA 3044/4885
US-20110089380-A1 Fullerene Multi-Adduct Compositions FTO, AKR1B10, DNMT1 CNR1 569/4885CNR2 401/4885LMNA 1168/4885
US-20170338415-A1 ORGANIC SEMICONDUCTOR SOLUTION BLENDS FOR SWITCHING AMBIPOLAR TRANSPORT TO N-TYPE TRANSPORT SLCO4C1, SLC5A11, AQP4 CNR1 4006/4885CNR2 3411/4885LMNA 3121/4885
US-20120111411-A1 FULLERENE DERIVATIVE HCN2, KCNN2, TMEM109 CNR1 2747/4885CNR2 1903/4885LMNA 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.